Cathay International Holdings Ld Notice of Interim Results 2016 (3452H)

TIDMCTI

RNS Number : 3452H

Cathay International Holdings Ld

17 August 2016

Cathay International Holdings Limited

("Cathay" or the "Company")

Notice of Interim Results 2016

Hong Kong, 17 August 2016 - Cathay International Holdings Ltd. (LSE: CTI.L), a leading operator and investor in the growing healthcare sector in the People's Republic of China, today announces that the Company will issue its Interim Results for the six months ended 30 June 2016 on Wednesday, 31 August 2016.

- ENDS -

For further enquiries, please contact:

 
 Cathay International Holdings 
  Limited                               Tel: [phone] 
  Eric Siu (Finance Director) 
  Patrick Sung (Director and 
  Controller) 
 N+1 Singer 
  Aubrey Powell / Lauren Kettle         Tel: [phone] 
  - Corporate Finance                   3000 
  Brough Ransom - Sales 
 Consilium Strategic Communications 
  Mary-Jane Elliott / Matthew           Tel: +44 (0) 203 
  Neal / Lindsey Neville                709 5702 
 

About Cathay

Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and a leading operator and investor in the growing healthcare sector in the People's Republic of China (the "PRC").

The Company and its subsidiaries (collectively the "Group") aim to leverage on growth opportunities in the strong and growing domestic demand for high quality healthcare products in the PRC and build its portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a strong track record of identifying high-growth potential investment opportunities in this area including: Lansen, a leading specialty pharmaceutical company focused on rheumatology and dermatology in the PRC; Haizi, a company engaged in the manufacture, marketing and sale of inositol and its by-product, di-calcium phosphate; Yangling, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.

The Group employs approximately 2,000 people across the PRC, including over 30 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment.

For more information please visit the Company's website: www.cathay-intl.com.hk

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORZMGMRDVMGVZM

(END) Dow Jones Newswires

August 17, 2016 02:01 ET (06:01 GMT)